CARD8 抗体 (AA 221-320) (Cy7)
Quick Overview for CARD8 抗体 (AA 221-320) (Cy7) (ABIN886496)
抗原
See all CARD8 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 221-320
-
预测反应
- Human
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human CARD8
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- CARD8 (Caspase Recruitment Domain Family, Member 8 (CARD8))
-
别名
- CARD8
-
背景
-
Synonyms: Apoptotic protein NDPP 1, Apoptotic protein NDPP1, CARD 8, CARD inhibitor of NF kappa B activating ligand, CARD inhibitor of NF kappaB activating ligand, CARD inhibitor of NF kappaB activating ligands, CARD-inhibitor of NF-kappa-B-activating ligand, CARD8, CARD8_HUMAN, CARDINAL, Caspase recruitment domain containing protein 8, Caspase recruitment domain family member 8, Caspase recruitment domain protein 8, Caspase recruitment domain-containing protein 8, DACAR, NDPP 1, NDPP1, TUCAN, Tumor up regulated CARD containing antagonist of CASP9, Tumor up regulated CARD containing antagonist of caspase 9, Tumor up-regulated CARD-containing antagonist of CASP9, Tumor upregulated CARD containing antagonist of CASP9.
Background: Inhibits NF-kappa-B activation. May participate in a regulatory mechanism that coordinates cellular responses controlled by NF-kappa-B transcription factor. May be a component of the inflammasome, a protein complex which also includes PYCARD, NALP2 and CASP1 and whose function would be the activation of proinflammatory caspases.
-
基因ID
- 22900
-
途径
- Positive Regulation of Endopeptidase Activity
抗原
-